mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.008 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.009 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |